Center for Scientific Review; Notice of Closed Meetings, 78319-78320 [2024-21898]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 186 / Wednesday, September 25, 2024 / Notices
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Chemistry and
Pharmacology of Substance Use Disorders.
Date: January 8, 2025.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Marisa Srivareerat, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 435–1258,
marisa.srivareerat@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: September 20, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–21958 Filed 9–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Environmental Determinants of Disease
Study Section.
Date: October 21–23, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
VerDate Sep<11>2014
17:28 Sep 24, 2024
Jkt 262001
Meeting Format: Virtual Meeting.
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Immune
Mechanisms of Hypersensitivity and Allergy
(IMHA).
Date: October 22–23, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Place National Harbor, 123
Waterfront St, National Harbor, MD 20745.
Meeting Format: In Person.
Contact Person: Deanna C. Bublitz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–4005, deanna.bublitz@
nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cellular,
Molecular and Integrative Reproduction
Study Section.
Date: October 22–23, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anthony Wing Sang Chan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 809K,
Bethesda, MD 20892, (301) 496–9392,
chana2@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group; Maximizing
Investigators’ Research Award C Study
Section.
Date: October 22–23, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20817.
Meeting Format: Virtual Meeting.
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–8559, jimok.kim@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Therapeutic Development and
Preclinical Studies Study Section.
Date: October 23–24, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Meeting Format: In Person and Virtual
Meeting.
Contact Person: Richard D Schneiderman,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
78319
Health, 6701 Rockledge Drive, Room 4138,
Bethesda, MD 20817, 301–402–3995,
richard.schneiderman@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neuroscience of
Basic Visual Processes Study Section.
Date: October 23–24, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: EVEN Hotel Rockville, Previously
Holiday Inn, 1775 Rockville Pike Rockville,
MD 20852.
Meeting Format: In Person.
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Social and
Community Influences on Health Integrated
Review Group; Community Influences on
Health Behavior Study Section.
Date: October 23–24, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza National Airport, 1480
Crystal Drive, Arlington, VA 22202.
Meeting Format: In Person.
Contact Person: Maria De Jesus Diaz Perez,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000G,
Bethesda, MD 20892, (301) 496–4227,
diazperezm2@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Healthcare and Health Disparities Study
Section.
Date: October 23–24, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tara Roshell Earl, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C,
Bethesda, MD 20892, (301) 402–6857, earltr@
mail.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Developmental Brain Disorders Study
Section.
Date: October 23–25, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Pat Manos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5200,
MSC 7846, Bethesda, MD 20892, (301) 408–
9866, manospa@csr.nih.gov.
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
E:\FR\FM\25SEN1.SGM
25SEN1
78320
Federal Register / Vol. 89, No. 186 / Wednesday, September 25, 2024 / Notices
Review Group; Advancing Therapeutics—B
Study Section.
Date: October 24–25, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lystranne Alysia Maynard
Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–402–4809,
lystranne.maynard-smith@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–21898 Filed 9–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Advancing Genomic Medicine
Research.
Date: October 29, 2024.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual).
Contact Person: Lori Bonnycastle, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3100, Bethesda, MD 20892, 301–594–
9206, lbonnyca@mail.nih.gov.
VerDate Sep<11>2014
17:28 Sep 24, 2024
Jkt 262001
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Regional Genomic Medicine eConsult
Services.
Date: November 13, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual).
Contact Person: Sarah J. Wheelan, MD,
Ph.D., Scientific Review Officer, National
Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3180, Bethesda, MD 20892, (301) 402–
8823, wheelansj@nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Training Grant.
Date: November 14, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, National Human
Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Suite 3100, Bethesda, MD 20892, (301) 402–
0838, pozzattr@mail.nih.gov.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Computational Genomics and Data
Science Education.
Date: November 18, 2024.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 3100, Bethesda, MD
20892 (Virtual).
Contact Person: Sarah J. Wheelan, MD,
Ph.D., Scientific Review Officer, National
Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive,
Room 3180, Bethesda, MD 20892, (301) 402–
8823, wheelansj@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–21900 Filed 9–24–24; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; URGenT: Translational
Efforts to Advance Gene-based Therapies for
Ultra-Rare Neurological and Neuromuscular
Disorders.
Date: October 17, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Mirela Milescu, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852,
mirela.milescu@nih.gov, 301–496–5720.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS).
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–21901 Filed 9–24–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–P
PO 00000
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 89, Number 186 (Wednesday, September 25, 2024)]
[Notices]
[Pages 78319-78320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21898]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Environmental Determinants of Disease Study
Section.
Date: October 21-23, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Stacey Nicole Williams, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Immune Mechanisms of Hypersensitivity and Allergy (IMHA).
Date: October 22-23, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Place National Harbor, 123 Waterfront St, National
Harbor, MD 20745.
Meeting Format: In Person.
Contact Person: Deanna C. Bublitz, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4005,
[email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Cellular, Molecular
and Integrative Reproduction Study Section.
Date: October 22-23, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Anthony Wing Sang Chan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institute of Health,
6701 Rockledge Drive, Room 809K, Bethesda, MD 20892, (301) 496-9392,
[email protected].
Name of Committee: Cell Biology Integrated Review Group;
Maximizing Investigators' Research Award C Study Section.
Date: October 22-23, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20817.
Meeting Format: Virtual Meeting.
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 402-8559,
[email protected].
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group; Therapeutic Development and Preclinical
Studies Study Section.
Date: October 23-24, 2024.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Meeting Format: In Person and Virtual Meeting.
Contact Person: Richard D Schneiderman, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-
402-3995, [email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Neuroscience of Basic Visual
Processes Study Section.
Date: October 23-24, 2024.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: EVEN Hotel Rockville, Previously Holiday Inn, 1775
Rockville Pike Rockville, MD 20852.
Meeting Format: In Person.
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].
Name of Committee: Social and Community Influences on Health
Integrated Review Group; Community Influences on Health Behavior
Study Section.
Date: October 23-24, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza National Airport, 1480 Crystal Drive,
Arlington, VA 22202.
Meeting Format: In Person.
Contact Person: Maria De Jesus Diaz Perez, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000G, Bethesda, MD 20892, (301)
496-4227, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Healthcare and Health Disparities Study
Section.
Date: October 23-24, 2024.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Tara Roshell Earl, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007C, Bethesda, MD 20892, (301)
402-6857, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Developmental Brain Disorders Study
Section.
Date: October 23-25, 2024.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Pat Manos, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5200, MSC 7846, Bethesda, MD 20892, (301) 408-
9866, [email protected].
Name of Committee: Interdisciplinary Molecular Sciences and
Training Integrated
[[Page 78320]]
Review Group; Advancing Therapeutics--B Study Section.
Date: October 24-25, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lystranne Alysia Maynard Smith, Ph.D.,
Scientific Review Officer, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-
402-4809, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: September 19, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-21898 Filed 9-24-24; 8:45 am]
BILLING CODE 4140-01-P
